Extramedullary Involvement of the Breast by Systemic Multiple Myeloma as the Initial Presentation of Plasma Cell Myeloma: A Rare Case Breast Plasmacytoma in MM
Abstract
Background: Extramedullary involvement by systemic multiple myeloma is a rare manifestation of plasma cell myeloma, most commonly arising in the upper aerodigestive tract. Breast involvement is exceptionally uncommon and can mimic primary or recurrent breast carcinoma, creating diagnostic challenges.
Case presentation: A 64-year-old woman with a history of invasive ductal carcinoma presented with a new breast lesion on screening mammography. Imaging demonstrated a small, circumscribed nodule, and core biopsy revealed monoclonal plasma cell infiltration. Magnetic resonance imaging (MRI) showed multiple breast lesions, while bone marrow biopsy confirmed more than 90% plasma cell involvement with high-risk cytogenetics, including 1q21 amplification. These findings established a diagnosis of extramedullary involvement of the breast by systemic multiple myeloma (MM). The patient was treated with daratumumab-based systemic therapy, achieving remission with eventual minimal residual disease negativity on follow-up testing. She remains without clinical or radiographic evidence of breast disease.
Conclusion: Breast involvement by systemic MM is a rare manifestation of plasma cell myeloma and should be considered in the differential diagnosis of new breast lesions. Early biopsy and comprehensive pathologic evaluation are essential to avoid misdiagnosis and guide appropriate systemic therapy.
References
Rajkumar SV. Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management. American J Hematol. 2018;93(8):1091-110. doi: 10.1002/ajh.25117
Luh SP, Lai YS, Tsai CH, Tsao TCY. Extramedullary plasmacytoma (EMP): Report of a case manifested as a mediastinal mass and multiple pulmonary nodules and review of literature. World J Surg Onc. 2007;5(1):123. doi: 10.1186/1477-7819-5-123
Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999;85(11):2305-14. doi: 10.1002/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3
Le DK, Metter D, Krause JR. Plasmablastic Plasmacytoma of the Breast. Baylor University Medical Center Proceedings. 2017;30(2):203-4. doi: 10.1080/08998280.2017.11929587
Ho M, Paruzzo L, Minehart J, Nabar N, Noll JH, Luo T, et al. Extramedullary Multiple Myeloma: Challenges and Opportunities. Current Oncology. 2025;32(3):182. doi: 10.3390/curroncol32030182
Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. The Lancet Oncology. 2019;20(6):e302-e312. doi: 10.1016/s1470-2045(19)30309-2
Park YM. Imaging Findings of Plasmacytoma of Both Breasts as a Preceding Manifestation of Multiple Myeloma. Case Reports in Medicine. 2016;2016(1):6595610. doi: 10.1155/2016/6595610
Fischer TRDC, Higashi F, Crusoe EDQ, Hungria VTDM. Bilateral breast plasmacytoma: a clinical case report. Revista Brasileira de Hematologia e Hemoterapia. 2016;38(2):166-9. doi: 10.1016/j.bjhh.2016.03.003
Urano M, Denewar FA, Okabe R, Komatsu H, Wanifuchi-Endo Y, Toyama T, et al. Relapsed multiple myeloma manifesting as extramedullary plasmacytoma of the breast: Imaging findings. Radiology Case Reports. 2019;14(5):584-7. doi: 10.1016/j.radcr.2019.02.018
Beydoun AS, Ovalle F, Brannock K, Gobble RM. A Case Report of a Breast Implant–Associated Plasmacytoma and Literature Review of Non-ALCL Breast Implant–Associated Neoplasms. Aesthetic Surgery Journal. 2019;39(7):NP234-NP239. doi: 10.1093/asj/sjy315
Vong S, Navarro SM, Darrow M, Aminololama-Shakeri S. Extramedullary Plasmacytoma of the breast in a patient with Multiple Myeloma. Radiology Case. 2020;14(12):14-23. doi: 10.3941/jrcr.v14i12.4110
Eden JK, Borgen R, Haq R, Dobrashian R. A rare imaging case of bilateral plasmacytoma of the breast. BJR|case reports. 2020;6(2):20190131. doi: 10.1259/bjrcr.20190131
Mehta M, Shah A, Shah I, Shah R, Suryanarayan U. Solitary Plasmacytoma of the Breast. Journal of Radiation and Cancer Research. 2021;12(1):33-5. doi: 10.4103/jrcr.jrcr_14_20
Tawel H, Hasen Y, Arrgebe H, ALGhanoudi A, Ali N, Elharari N, et al. Breast Plasmacytoma as Extra-Medullary Lesion of Multiple Myeloma: A Case Report. J Investig Med High Impact Case Rep. 2022;10:23247096221111773. doi: 10.1177/23247096221111773
Mo CKM, Lai AYT, Lo SSW, Wong TS, Wong WWC. Bilateral breast multiple myeloma: a case report. Hong Kong Med J. 2022;28(6):488-90. doi: 10.12809/hkmj219555
McCormack S, Hamad E, Hamad A. Solitary Plasmacytoma of the Breast: A Case of an Uncommon Breast Neoplasm. Case Reports in Hematology. 2023;2023:1-5. doi: 10.1155/2023/9622042
Shiva S, Gaurav K, Anand A, Raghuvanshi S, Sonkar AA. Solitary Plasmacytoma of the Breast: A Rare Entity. Cureus. 2024. doi: 10.7759/cureus.53612
Madan NK, Malik S, Ahuja S. Isolated plasmacytoma of the breast: A rare case report. International Journal of Surgery Case Reports. 2024;125(C). doi: 10.1016/j.ijscr.2024.110654
Alsaleh B, Alanzi A, Alsaeed M, Farahat A, Alsaleh M, Mohamed H. Bilateral Breast Involvement in Multiple Myeloma: A Report of a Rare Case. Cureus. 2024. doi: 10.7759/cureus.70906
Venkataraman P, Mehra N, Sundersingh S, Iyer P. Extramedullary Disease of the Breast in Multiple Myeloma—An Uncommon Initial Presentation: A Case Report and Review of Literature. Indian J Med Paediatr Oncol. 2025. doi: 10.1055/s-0044-1801769
Silva MJ, Patel J, Huang A, Lo Gullo R, Pinker-Domenig K. Breast Plasmacytoma as the Initial Manifestation of Multiple Myeloma in a 36-Year-Old Woman. Cureus. 2025. doi: 10.7759/cureus.87929
LIU Y, HE Z, WANG M, LANG J, ZHOU Y, WANG C. Multiple Myeloma Concurrent with Extramedullary Plasmacytoma of the Breast: A Case Report and Literature Review. Medical Journal of Peking Union Medical College Hospital. 2025;16(4):1002-1007.
Messina G, Fucile MA, Kupper M, Campitiello M, Plastino F, Legros PO, et al. Multiple Myeloma Presenting as Breast Metastasis: Diagnostic Challenges and Case Analysis. Am J Case Rep. 2025;26. doi: 10.12659/ajcr.945853
Eņģele I, Zablocka T, Asere E, Eglītis J. Bilateral breast plasmacytomas in a male patient with relapsed multiple myeloma: A case report. Radiology Case Reports. 2026;21(3):1231-5. doi: 10.1016/j.radcr.2025.11.054
Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229-53. doi: 10.1182/blood.2022015851
Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBDO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720-48. doi: 10.1038/s41375-022-01620-2
Gregory CC, Parks RM, Srajagopal N, Gutteridge E. A rare case of extramedullary plasmacytoma in the breast – an incidental finding in a 100-year-old following a fall. Ann R Coll Surg Engl. 2026;108(6):487-9. doi: 10.1308/rcsann.2025.0068
Dass J, Arava S, Mishra PC, Dinda AK, Pati HP. Role of CD138, CD56, and light chain immunohistochemistry in suspected and diagnosed plasma cell myeloma: A prospective study. South Asian J Cancer. 2019;8(1):60-4. doi: 10.4103/sajc.sajc_64_17
Bal S, Kumar SK, Fonseca R, Gay F, Hungria VTM, Dogan A, et al. Multiple myeloma with t(11;14): unique biology and evolving landscape. Am J Cancer Res. 2022;12(7):2950-65.
Padhi S, G’Boy Varghese R, Ramdas A. Cyclin D1 expression in multiple myeloma by immunohistochemistry: Case series of 14 patients and literature review. Indian Journal of Medical and Paediatric Oncology. 2013;34(04):283-91. doi: 10.4103/0971-5851.125246
Zhao J, Cui Y, Fang B. Therapeutic options for extramedullary involvement in multiple myeloma. Clin Exp Med. 2025;25(1):301. doi: 10.1007/s10238-025-01821-w
Bisht K, Walker B, Kumar SK, Spicka I, Moreau P, Martin T, et al. Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies. Expert Review of Hematology. 2021;14(12):1099-114. doi: 10.1080/17474086.2021.1983427
Perrot A, Lauwers-Cances V, Tournay E, Hulin C, Chretien ML, Royer B, et al. Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma. JCO. 2019;37(19):1657-65. doi: 10.1200/jco.18.00776
Terpos E, Morgan G, Dimopoulos MA, Drake MT, Lentzsch S, Raje N, et al. International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease. JCO. 2013;31(18):2347-57. doi: 10.1200/jco.2012.47.7901
Authors
Copyright (c) 2026 Natalia Correa, Maya Kumar, Lynell Martinez, Christopher Montoya, Ashli Alexander, Simon Blanc, Jessica Burgers

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.